PMVP - PMV Pharmaceuticals, Inc.
1.23
0 0%
Share volume: 258,412
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.23
0.00
0.00%
Fundamental analysis
16%
Profitability
0%
Dept financing
28%
Liquidity
50%
Performance
20%
Performance
5 Days
0 0%
1 Month
-12.14%
3 Months
-21.66%
6 Months
-18.54%
1 Year
-24.54%
2 Year
-77.76%
Key data
Stock price
$1.23
DAY RANGE
$1.20 - $1.28
52 WEEK RANGE
$1.20 - $2.26
52 WEEK CHANGE
-$25.45
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail

CEO: David H. Mack
Region: US
Website: pmvpharma.com
Employees: 50
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
Region: US
Website: pmvpharma.com
Employees: 50
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing
PMV Pharmaceuticals, Inc. engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.
Recent news